Voyager Therapeutics Names Robin Swartz President

Bitget2026/10/21 12:10

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Voyager Therapeutics appointed Robin Swartz president, effective October 20, 2026. She previously served as chief business officer and chief operating officer.
Swartz is expected to succeed Alfred W. Sandrock, Jr. as CEO in the first quarter of 2027.
The transition follows initial acute safety data from the VY1706 trial in adults with early Alzheimer's disease, expected that quarter pending enrollment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Voyager Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610210801PRIMZONEFULLFEED9849985) on October 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Voyager Therapeutics Names Robin Swartz President

You may also like

Crypto prices